Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line
BACKGROUND: Histone deacetylase (HDAC) inhibitors combined with other drugs for the treatment of malignant tumors are used more and more widely. In this study, we investigated the effect of trichostatin A (TSA), a HDAC inhibitor, in combination with cisplatin, a cytotoxic chemotherapy agent, on the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448485/ https://www.ncbi.nlm.nih.gov/pubmed/26273359 http://dx.doi.org/10.1111/1759-7714.12167 |